Format

Send to

Choose Destination
Pediatr Radiol. 2016 Oct;46(11):1494-506. doi: 10.1007/s00247-016-3643-6. Epub 2016 Jul 23.

The changing face of complicated infantile hemangioma treatment.

Author information

1
Phoenix Regional Campus, Creighton University School of Medicine, Phoenix, AZ, USA.
2
Department of Otorhinolaryngology, Mayo School of Graduate Medical Education-MN, Rochester, MN, USA.
3
Department of Radiology, Phoenix Children's Hospital, Phoenix, AZ, USA.
4
Division of Dermatology, University of California, Los Angeles, 1245 16th Street, suite 204, Santa Monica, CA, 90404, USA. hogelingm@yahoo.ca.

Abstract

Infantile hemangiomas are the most common vascular tumors of infancy. A multidisciplinary approach including dermatologists, otolaryngologists, plastic surgeons, hematologists/oncologists and interventional/diagnostic radiologists is crucial for appropriate management of children with complicated infantile hemangiomas. Since its unforeseen discovery in 2008, propranolol has become the first-line treatment for infantile hemangiomas, eclipsing systemic corticosteroids and radiologic intervention. There are still, however, uncommon indications for more aggressive interventional management. We review the 2014-updated International Society for the Study of Vascular Anomalies (ISSVA) classification for vascular anomalies. Additionally, we suggest management algorithms for complicated lesions, including recommendations for radiologic and surgical intervention.

KEYWORDS:

Children; Embolization; Infantile hemangioma; Interventional radiology; Magnetic resonance imaging; Propranolol

PMID:
27450406
DOI:
10.1007/s00247-016-3643-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center